Fucoxanthin and lipid metabolism: A minireview

Keyphrases

• Lipid Metabolism 100%
• Fucoxanthin 100%
• Lipolytic Enzymes 25%
• Clinical Trials 12%
• High-fat Diet 12%
• Carotenoids 12%
• Liver 12%
• Cholesterol 12%
• Diabetic 12%
• Type 2 Diabetes Mellitus (T2DM) 12%
• Data Synthesis 12%
• Adiposity 12%
• Insulin Resistance 12%
• Weight Gain 12%
• Rodents 12%
• Visceral Adipose Tissue 12%
• Visceral Fat 12%
• Diabetes Disease 12%
• Obesity Treatment 12%
• Adiponectin 12%
• Therapeutic Value 12%
• Plasma Parameters 12%
• Low-density Lipoprotein 12%
• Heart Disease 12%
• Mitogen-activated Protein Kinase 12%
• Syndrome Type 12%
• Metabolic Syndrome 12%
• Leptin 12%
• Related Conditions 12%
• Body Fat 12%
• Plasma Lipid Profile 12%
• Nutritional Supplements 12%
• Anti-obesity 12%
• Insulin Signaling 12%
• Lipid Accumulation 12%
• Common Target 12%
• Adipocyte Differentiation 12%
• Seaweed 12%
• Food Culture 12%
• East Asian Countries 12%
• Food Supplementation 12%
• KKAy Mice 12%
• Essential Health Benefits 12%
• Southeast Asian 12%
• Brown Seaweed 12%
• Uncoupling Protein 12%
• Obesity Prevention 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Fucoxanthin 100%
• Kelp 25%
• Clinical Trial 12%
• Heart Disease 12%
• Carotenoid 12%
• Non Insulin Dependent Diabetes Mellitus 12%
• Insulin Resistance 12%
• Obesity 12%
• Adiponectin 12%
• Metabolic Syndrome X 12%
• Protein Kinases 12%
• Leptin 12%
• Low Density Lipoprotein 12%
• Nutrition Supplement 12%
• KK-Ay Mouse 12%
• Uncoupling Protein 12%
• Diabetic Obesity 12%